Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases

Of the 80 solid tumor cases in which liquid biopsy (LB) was performed using Guardant360 in the PROFILE study, nine were lung cancer cases. Here, we review three cases in which LB was useful in diagnosing ALK fusion‐positive lung cancer, selecting sequential ALK‐tyrosine kinase inhibitors, confirming...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitsumura, Takahiro, Kumaki, Yuichi, Takahashi, Kenta, Matsudera, Shotaro, Sakakibara, Rie, Honda, Takayuki, Ishizuka, Masahiro, Iijima, Yuki, Shirai, Tsuyoshi, Okamoto, Tsukasa, Tateishi, Tomoya, Sakashita, Hiroyuki, Miyake, Satoshi, Ikeda, Sadakatsu, Miyazaki, Yasunari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447906/
https://www.ncbi.nlm.nih.gov/pubmed/34378333
http://dx.doi.org/10.1111/1759-7714.14098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447906/
https://www.ncbi.nlm.nih.gov/pubmed/34378333
http://dx.doi.org/10.1111/1759-7714.14098

Ejemplares similares